Enea signs 1.8 MUSD Bridged Services deal with US medtech company
STOCKHOLM, Sweden, May 5, 2014 – Enea® (NASDAQ OMX Nordic:ENEA) and a leading US medical technology company has signed a service agreement valued at 1.8 MUSD. The agreement is an extension covering 2014 with one of Enea’s long-term customers.
Enea delivers the solution within Enea’s Bridged Services model, which combines international engineering expertise across several delivery sites, strengthened by onsite program managers. In this case, Enea’s Romania team manages architecture, development and engineering, and Enea’s North America team is responsible for program management and delivery.
Enea is the customer’s main contributor of outsourced product R&D services for developing and maintaining next generation software for the customer’s infusion technologies. Furthermore, Enea provides the quality assurance required by the FDA, including development of a hardware platform to automate the infusion system in the lab, development and integration of a re-usable test framework, development of all the test scripts needed, execution and management of all the test automation, as well as execution of all the manual testing that the automation framework does not handle.
“Enea has extensive experience in developing software and providing services for stringent and process-driven applications and devices”, says Anders Lidbeck, President and CEO for Enea. “The customer’s renewed trust in Enea is a testament to our successful track record in managing offshore engineering teams within our Bridged Services model.”
This is information of the type that Enea AB (publ) is obligated to disclose in accordance with the Swedish Securities Markets Act and/or the Financial Instruments Trading Act. The information was submitted for publication on May 5, 2014, at 11:00 CET.